Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2006-11-14
2006-11-14
Zeman, Robert A. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S184100, C424S130100, C424S139100, C424S141100, C424S142100, C424S152100, C424S172100, C530S350000, C530S387100, C530S387900, C530S388100, C530S388150, C530S389100
Reexamination Certificate
active
07135182
ABSTRACT:
The infection of a mammalian host by a microorganism can be prevented or treated through the administration of substrates for transglutaminases or antibodies against such substrates that inhibit the transglutaminase-mediated interaction of the microorganism with the mammalian host. These compounds may be used in the identification, prevention or treatment of microbial infection of mammalian hosts such as immunocompromised or immunosuppressed humans, for example, those having AIDS or undergoing transplantation or anti-cancer therapy.
REFERENCES:
Sundstrom et al. (Journal of Infectious Diseases, vol. 185, pp. 521-530, 2002).
Bowie et al (Science, 1990, 257:1306-1310).
Dermer (Bio/Technology, 1994, vol. 12 p. 320).
Freshney (Culture of Animal Cells, A Manual of Basic Technique, Alan R. Liss, Inc., 1983, New York, p. 4).
J. Staab et al.,J. Biol. Chem., 271(11) 6298-6305 (Mar. 1996).
J. Staab et al.,Yeast, 14, 681-686 (1998).
J. Staab et al.,Database EMBL(online), Accession No. U64206 (Apr. 1997).
J. Staab et al.,Abstracts of the General Meeting of the American Society for Microbiology, 97(0), 339 (May 1997).
X. Wang et al.,Abstracts of the General Meeting of the American Society for Microbiology, 97(0), 596 (May 1997),
J. Staab et al.,Science, 283, 1535-1538 (Mar. 5, 1999).
P. Sundstrom,Curr. Opin. Microbiol., 2(4), 353-357 (Aug. 1999).
L. Sharkey et al.,Database EMBL(online), Accession No. AF001978 (Jun. 1997).
L. Sharkey et al.,J. Bact., 181(17), 5273-5279 (Sep. 1999).
P. Sundstrom et al.,Infection and Immunity, 55(3), 616-620 (Mar. 1987).
AAB64014 Genbank Jun. 23, 1997.
Bradway Steven D.
Sundstrom Paula
Licata & Tyrrell P.C.
Trustees of Dartmouth College
Zeman Robert A.
LandOfFree
Inhibition of transglutaminase-mediated microbial... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of transglutaminase-mediated microbial..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of transglutaminase-mediated microbial... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3645481